Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inturned planar cell polarity protein (INTU) is a key multifunctional protein involved in both the assembly and function of primary cilia and the regulation of planar cell polarity during embryonic development[1][4]. It acts as a core component of the CPLANE complex, essential for organizing the apical actin cytoskeleton, recruitment of CPLANE proteins, and correct positioning of basal bodies, all of which underpin the formation of primary cilia and the transmission of associated signaling pathways[1][4]. INTU is specifically implicated in developmental processes such as the formation of digits, palate, and tongue. Loss-of-function or hypomorphic mutations in INTU are linked to developmental disorders and ciliopathies, especially orofaciodigital syndrome XVII and short-rib thoracic dysplasia with polydactyly[1][4][5]. INTU has no direct evidence as a therapeutic drug target, nor are there known pharmacological agents or drugs acting on it[1][4]. However, it has roles in modulating the degradation of STAT1 and maintaining cellular homeostasis during stress in certain adult tissues, such as kidneys[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inturned planar cell polarity protein (INTU).